Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.97 |
| ▸ | MAPT | P10636 | 1/20 | 0.97 |
| ▸ | TSHR | P16473 | 4/20 | 0.77 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.77 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.77 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.77 |
| ▸ | DRD1 | P21728 | 3/20 | 0.77 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.77 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.77 |
| ▸ | HTR2A | P28223 | 2/20 | 0.77 |
| ▸ | HRH1 | P35367 | 2/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.77 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | HTR1A | P08908 | 1/20 | 0.77 |
| ▸ | HTR2C | P28335 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thonzylamine SCHEMBL29417 | 0.98 | LMNA (1.00) | LMNAMAPTTSHRCYP1A2CYP2D6 | |
| Thonzylamine SCHEMBL1650305 | 0.98 | LMNA (0.94) | LMNAMAPTTSHRCYP1A2CYP2D6 | |
| Pyrilamine SCHEMBL28086659 | 0.91 | LMNA (0.95) | LMNAMAPTTSHRCYP1A2CYP2D6 | |
| SCHEMBL28298127 | 0.89 | LMNA (0.77) | LMNAMAPTTSHRCYP1A2CYP2D6 | |
| Pyrilamine SCHEMBL4075657 | 0.88 | LMNA (0.90) | LMNAMAPTTSHRCYP1A2CYP2D6 | |
| SCHEMBL17817354 | 0.88 | LMNA (0.76) | LMNAMAPTTSHRCYP1A2CYP2D6 | |
| Pyrilamine SCHEMBL29444024 | 0.87 | LMNA (1.00) | LMNAMAPTTSHRCYP1A2CYP2D6 | |
| Pyrilamine SCHEMBL19114 | 0.87 | LMNA (1.00) | LMNAMAPTTSHRCYP1A2CYP2D6 | |
| Pyrilamine SCHEMBL22118219 | 0.86 | LMNA (0.97) | LMNAMAPTTSHRCYP1A2CYP2D6 | |
| Pyrilamine SCHEMBL28823277 | 0.86 | LMNA (0.97) | LMNAMAPTTSHRCYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731194-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP Technologies, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4691492-A2 | LIQUID COMPOSITIONS | Kenvue Brands LLC (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2025264260-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP TECHNOLOGIES, INC. (US) | 2025-12-26 | — | — | WO | claimed |
| EP-4154879-B1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NICOTINE WITHDRAWAL SYMPTOMS | KOREA INST SCI & TECH (KR) | 2025-09-10 | — | — | EP | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-115219862-B | Space arc fault detection method, system and storage medium | 哈尔滨工业大学（深圳） | 2025-05-06 | — | — | CN | claimed |
| WO-2024263560-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP TECHNOLOGIES, INC. (US) | 2024-12-26 | — | — | WO | claimed |
| WO-2024229174-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2024-11-07 | — | — | WO | claimed |
| CN-112163592-B | Method for recognizing and early warning pedestrian state by using mobile phone and smart phone thereof | 江苏大学 | 2024-05-14 | — | — | CN | claimed |
| WO-2007026151-A1 | ANTIHISTAMINE- AND CORTICOSTEROID- CONTAINING LIPOSOME COMPOSITION AND ITS USE FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING RHINITIS AND RELATED DISORDERS | BIOLIPOX AB (SE) | 2007-03-08 | — | — | WO | claimed |
| WO-2006131737-A2 | METHOD AND COMPOSITION FOR TREATING INFLAMMATORY DISORDERS | BIOLIPOX AB (SE) | 2006-12-14 | — | — | WO | claimed |
| US-20060057205-A1 | Phenylepherine containing dosage form | SOVEREIGN PHARMACEUTICALS, LTD. (US) | 2006-03-16 | — | — | US | claimed |
| WO-2006022996-A2 | DOSAGE FORM CONTAINING MULTIPLE DRUGS | SOVEREIGN PHARMACEUTICALS, LTD. (US) | 2006-03-02 | — | — | WO | claimed |
| US-20050266032-A1 | Dosage form containing multiple drugs | SOVEREIGN PHARMACEUTICALS, LTD. (US) | 2005-12-01 | — | — | US | claimed |
| WO-2005094832-A1 | COMPOSITIONS COMPRISING MELOXICAM | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-10-13 | — | — | WO | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-0517160-B1 | Extended-release ophthalmic preparations | INVERNI DELLA BEFFA SPA (IT) | 1996-03-13 | — | — | EP | claimed |
| US-5183665-A | Using antihistamine | NITTO DENKO CORPORATION (JP) | 1993-02-02 | — | — | US | claimed |
| EP-0517160-A1 | Extended-release ophthalmic preparations | INVERNI DELLA BEFFA S.P.A. (IT) | 1992-12-09 | — | — | EP | claimed |